2017 KSID临床指南:社区获得性皮肤和软组织感染的抗生素治疗

2017-12-04 韩国感染病学会 Infect Chemother. 2017 Dec;49(4):301-325.

皮肤和软组织感染是常见的重要的感染性疾病,本文是对2012年韩国皮肤和软组织感染指南的更新,文章主要对皮肤和软组织感染的诊断和管理提出指导建议,包括脓包疮/脓疮,化脓性皮肤软组织感染,丹毒和蜂窝织炎,坏死性筋膜炎,化脓性肌炎,气性坏疽以及咬伤。该指南主要面向大于等于16岁人群社区获得性皮肤和软组织感染患者。

中文标题:

2017 KSID临床指南:社区获得性皮肤和软组织感染的抗生素治疗

英文标题:

Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection.

发布机构:

韩国感染病学会

发布日期:

2017-12-04

简要介绍:

皮肤和软组织感染是常见的重要的感染性疾病,本文是对2012年韩国皮肤和软组织感染指南的更新,文章主要对皮肤和软组织感染的诊断和管理提出指导建议,包括脓包疮/脓疮,化脓性皮肤软组织感染,丹毒和蜂窝织炎,坏死性筋膜炎,化脓性肌炎,气性坏疽以及咬伤。该指南主要面向大于等于16岁人群社区获得性皮肤和软组织感染患者。

 

拓展指南:感染相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 KSID临床指南:社区获得性皮肤和软组织感染的抗生素治疗)] GetToolGuiderByIdResponse(projectId=1, id=254771c0015a18f8, title=2017 KSID临床指南:社区获得性皮肤和软组织感染的抗生素治疗, enTitle=Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection., guiderFrom=Infect Chemother. 2017 Dec;49(4):301-325., authorId=null, author=, summary=皮肤和软组织感染是常见的重要的感染性疾病,本文是对2012年韩国皮肤和软组织感染指南的更新,文章主要对皮肤和软组织感染的诊断和管理提出指导建议,包括脓包疮/脓疮,化脓性皮肤软组织感染,丹毒和蜂窝织炎,坏死性筋膜炎,化脓性肌炎,气性坏疽以及咬伤。该指南主要面向大于等于16岁人群社区获得性皮肤和软组织感染患者。 , cover=, journalId=null, articlesId=null, associationId=1578, associationName=韩国感染病学会, associationIntro=, copyright=0, guiderPublishedTime=Mon Dec 04 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>皮肤和软组织感染是常见的重要的感染性疾病,本文是对2012年韩国皮肤和软组织感染指南的更新,文章主要对皮肤和软组织感染的诊断和管理提出指导建议,包括脓包疮/脓疮,化脓性皮肤软组织感染,丹毒和蜂窝织炎,坏死性筋膜炎,化脓性肌炎,气性坏疽以及咬伤。该指南主要面向大于等于16岁人群社区获得性皮肤和软组织感染患者。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>感染</FONT>相关指南:</STRONG><BR> <UL> <LI><A title="2017 ESPGHAN意见书:儿童慢性丙肝感染的治疗" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=f36541c0015a0175">2017 ESPGHAN意见书:儿童慢性丙肝感染的治疗</A> <LI><A title=HPV感染疾病相关问题专家共识(2017) target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=9df0c1c00153e174">HPV感染疾病相关问题专家共识(2017)</A> <LI><A title=泌尿道感染诊治循证指南(2016) target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=263b91c00153ae65">泌尿道感染诊治循证指南(2016)</A> <LI><A title=NCCN临床实践指南:癌症相关感染的预防和治疗(2018.V1) target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=a87a61c0015305d1">NCCN临床实践指南:癌症相关感染的预防和治疗(2018.V1)</A> <LI><A title=感染性疾病相关个体化医学分子检测技术指南 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=ce1ae1c00152958c">感染性疾病相关个体化医学分子检测技术指南</A> 更多信息请点击:<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E6%84%9F%E6%9F%93">有关感染更多指南</A></LI></UL>, tagList=[TagDto(tagId=68004, tagName=社区获得性皮肤和软组织感染), TagDto(tagId=4247, tagName=抗生素治疗)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7487, appHits=262, showAppHits=0, pcHits=4875, showPcHits=3219, likes=131, shares=11, comments=11, approvalStatus=1, publishedTime=Tue Jan 09 22:38:17 CST 2018, publishedTimeString=2017-12-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jan 09 22:38:17 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:37:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 KSID临床指南:社区获得性皮肤和软组织感染的抗生素治疗)])
2017 KSID临床指南:社区获得性皮肤和软组织感染的抗生素治疗
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1194339, encodeId=18bf1194339b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad56507164, createdName=ms9000001162788533, createdTime=Thu Feb 17 09:24:44 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964091, encodeId=fae896409141, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Sun May 09 21:17:12 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277848, encodeId=2f382e7848a9, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Fri Jan 12 14:00:42 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277836, encodeId=e6eb2e783662, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jan 12 13:51:35 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277801, encodeId=0d952e780119, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jan 12 10:02:39 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2022-02-17 ms9000001162788533

    学习一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1194339, encodeId=18bf1194339b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad56507164, createdName=ms9000001162788533, createdTime=Thu Feb 17 09:24:44 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964091, encodeId=fae896409141, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Sun May 09 21:17:12 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277848, encodeId=2f382e7848a9, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Fri Jan 12 14:00:42 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277836, encodeId=e6eb2e783662, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jan 12 13:51:35 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277801, encodeId=0d952e780119, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jan 12 10:02:39 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2021-05-09 美尼尔

    学习学习.了解了解

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1194339, encodeId=18bf1194339b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad56507164, createdName=ms9000001162788533, createdTime=Thu Feb 17 09:24:44 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964091, encodeId=fae896409141, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Sun May 09 21:17:12 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277848, encodeId=2f382e7848a9, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Fri Jan 12 14:00:42 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277836, encodeId=e6eb2e783662, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jan 12 13:51:35 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277801, encodeId=0d952e780119, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jan 12 10:02:39 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-01-12 1e0e5a1fm42(暂无匿称)

    henhao

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1194339, encodeId=18bf1194339b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad56507164, createdName=ms9000001162788533, createdTime=Thu Feb 17 09:24:44 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964091, encodeId=fae896409141, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Sun May 09 21:17:12 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277848, encodeId=2f382e7848a9, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Fri Jan 12 14:00:42 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277836, encodeId=e6eb2e783662, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jan 12 13:51:35 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277801, encodeId=0d952e780119, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jan 12 10:02:39 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-01-12 137****9095

    henhao

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1194339, encodeId=18bf1194339b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad56507164, createdName=ms9000001162788533, createdTime=Thu Feb 17 09:24:44 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964091, encodeId=fae896409141, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Sun May 09 21:17:12 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277848, encodeId=2f382e7848a9, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Fri Jan 12 14:00:42 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277836, encodeId=e6eb2e783662, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jan 12 13:51:35 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277801, encodeId=0d952e780119, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jan 12 10:02:39 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-01-12 大爰

    学习了谢谢分享!!

    0